Drugs Made In America Acquisition DMAA
NASDAQ DMAA
$10.91 +0.01 (+0.09%)
At close: Nov 13, 2026 · 4:00 PM EST

Drugs Made In America Acquisition (DMAA) Change in Accrued Expenses (2024 - 2026)

Updated

Drugs Made In America Acquisition's Change in Accrued Expenses was -$80,439 in Q4 2025.

Analysis

Drugs Made In America Acquisition (DMAA) Change in Accrued Expenses (2024 - 2026) Analysis & Trends

For FY2025, Change in Accrued Expenses at Drugs Made In America Acquisition came in at $144,904, up 87.5% from FY2024.

  • In earlier years, Change in Accrued Expenses was $77,280 in FY2024.
  • Per Business Quant data, DMAA's Change in Accrued Expenses in the three quarters before Q4 2025 was $155,170 (Q3 2025), $14,970 (Q2 2025) and $55,203 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 BlackRock 189.07 Bn 145.60 Bn - 1.01 Bn
2 Spdr Gold Trust 125.11 Bn -432.90 Bn - -
3 Brookfield 101.47 Bn -96.66 Bn - -
4 Blackstone 91.35 Bn 85.56 Bn - 32.40 Mn
5 Kkr 87.89 Bn 54.59 Bn 1.76 Bn -185.40 Mn
6 Brookfield Asset Management 82.34 Bn 77.22 Bn - -
7 Apollo Global Management 72.94 Bn 89.74 Bn 4.14 Bn -
8 Wheaton Precious Metals 59.70 Bn 59.70 Bn 538.50 Mn -
9 Ares Management 48.49 Bn 47.07 Bn 376.28 Mn -
10 Drugs Made In America Acquisition 336.16 Mn 336.12 Mn - -58,769.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -58,769.00
Mar 31, 2026 15,997.00
Dec 31, 2025 -80,439.00
Sep 30, 2025 155,170.00
Jun 30, 2025 14,970.00
Mar 31, 2025 55,203.00
Sep 30, 2024 7,400.00
API Access

Drugs Made In America Acquisition Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=DMAA&period=max&api_key=YOUR_API_KEY